Stockreport

NeoGenomics Reports Fourth Quarter and Full Year 2025 Results

NeoGenomics, Inc.  (NEO) 
Last neogenomics, inc. earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.neogenomics.com
PDF Full-year revenue increased 10% to $727 million;Full-year clinical revenue grew 15%, or 13% excluding the Pathline acquisition;Successfully resolved RaDaR ST patent liti [Read more]